Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.26 Million EUR | 7.85% |
| 2022 | -2.45 Million EUR | -341.29% |
| 2021 | -557 Thousand EUR | 84.4% |
| 2020 | -3.57 Million EUR | 19.56% |
| 2019 | -4.43 Million EUR | 14.56% |
| 2018 | -5.19 Million EUR | -42.81% |
| 2017 | -3.63 Million EUR | -128.17% |
| 2016 | -1.59 Million EUR | 44.3% |
| 2015 | -2.86 Million EUR | -19.8% |
| 2014 | -2.38 Million EUR | -146.54% |
| 2013 | -969 Thousand EUR | 20.51% |
| 2012 | -1.21 Million EUR | -28.05% |
| 2011 | -952 Thousand EUR | 82.77% |
| 2010 | -5.52 Million EUR | 11.75% |
| 2009 | -6.26 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -711 Thousand EUR | 0.0% |
| 2023 Q4 | -1.34 Million EUR | 0.0% |
| 2023 Q2 | 512 Thousand EUR | 305571.64% |
| 2023 FY | -2.26 Million EUR | 7.85% |
| 2023 Q1 | 167.50 EUR | 100.01% |
| 2022 Q4 | -1.47 Million EUR | 0.0% |
| 2022 FY | -2.45 Million EUR | -341.29% |
| 2022 Q2 | -613 Thousand EUR | 55.55% |
| 2022 Q1 | -1.37 Million EUR | -22.04% |
| 2021 FY | -557 Thousand EUR | 84.4% |
| 2021 Q1 | -319.5 Thousand EUR | 88.72% |
| 2021 Q2 | -969 Thousand EUR | -203.29% |
| 2021 Q4 | -1.13 Million EUR | 0.0% |
| 2020 Q1 | -564.5 Thousand EUR | 82.58% |
| 2020 Q3 | -1.22 Million EUR | 23.77% |
| 2020 Q2 | -1.6 Million EUR | -183.61% |
| 2020 Q4 | -2.83 Million EUR | -132.12% |
| 2020 FY | -3.57 Million EUR | 19.56% |
| 2019 FY | -4.43 Million EUR | 14.56% |
| 2019 Q4 | -3.24 Million EUR | -162.67% |
| 2019 Q3 | -1.23 Million EUR | -54.67% |
| 2019 Q1 | -797.5 Thousand EUR | 51.73% |
| 2019 Q2 | -797.5 Thousand EUR | 0.0% |
| 2018 Q1 | -888 Thousand EUR | -6.6% |
| 2018 FY | -5.19 Million EUR | -42.81% |
| 2018 Q4 | -1.65 Million EUR | 0.0% |
| 2018 Q3 | -1.65 Million EUR | -86.04% |
| 2018 Q2 | -888 Thousand EUR | 0.0% |
| 2017 FY | -3.63 Million EUR | -128.17% |
| 2017 Q3 | -833 Thousand EUR | 17.4% |
| 2017 Q4 | -833 Thousand EUR | 0.0% |
| 2017 Q1 | -1 Million EUR | -347.23% |
| 2017 Q2 | -1 Million EUR | 0.0% |
| 2016 FY | -1.59 Million EUR | 44.3% |
| 2016 Q3 | -225.5 Thousand EUR | -15.94% |
| 2016 Q4 | -225.5 Thousand EUR | 0.0% |
| 2016 Q1 | -194.5 Thousand EUR | 73.68% |
| 2016 Q2 | -194.5 Thousand EUR | 0.0% |
| 2015 Q2 | -566 Thousand EUR | 0.0% |
| 2015 Q4 | -739 Thousand EUR | 0.0% |
| 2015 Q3 | -739 Thousand EUR | -30.57% |
| 2015 Q1 | -566 Thousand EUR | -166.35% |
| 2015 FY | -2.86 Million EUR | -19.8% |
| 2014 Q4 | -212.5 Thousand EUR | 0.0% |
| 2014 FY | -2.38 Million EUR | -146.54% |
| 2014 Q3 | -212.5 Thousand EUR | 15.17% |
| 2014 Q1 | -250.5 Thousand EUR | -265.89% |
| 2014 Q2 | -250.5 Thousand EUR | 0.0% |
| 2013 Q2 | -305.5 Thousand EUR | 0.0% |
| 2013 Q1 | -305.5 Thousand EUR | 0.0% |
| 2013 FY | -969 Thousand EUR | 20.51% |
| 2013 Q4 | 151 Thousand EUR | 0.0% |
| 2013 Q3 | 151 Thousand EUR | 149.43% |
| 2012 FY | -1.21 Million EUR | -28.05% |
| 2011 FY | -952 Thousand EUR | 82.77% |
| 2010 FY | -5.52 Million EUR | 11.75% |
| 2009 FY | -6.26 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | 82.665% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -40.451% |
| Carmat SA | -52.51 Million EUR | 95.687% |
| Euromedis Groupe | -5.55 Million EUR | 59.242% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 122.335% |
| Ikonisys S.A. | -2.19 Million EUR | -3.249% |
| Implanet S.A. | -6.15 Million EUR | 63.225% |
| Median Technologies SA | -23 Million EUR | 90.155% |
| SpineGuard SA | -3.97 Million EUR | 43.035% |
| Theraclion SA | -3.15 Million EUR | 28.186% |
| Euroapi S.A. | -234.3 Million EUR | 99.033% |
| Guerbet SA | 38.67 Million EUR | 105.857% |
| Ion Beam Applications SA | 5.09 Million EUR | 144.482% |
| Koninklijke Philips N.V. | -115 Million EUR | 98.03% |
| Sequana Medical NV | -29.49 Million EUR | 92.32% |